Hyperuricemic Syndromes: Pathophysiology and Therapy
A compendium of present knowledge
Uric acid disorders are involved in both nephrological and hematological diseases. One of these crystal-associated diseases which has been known since antiquity is gout. More recently, tumor Lysis syndromes have been identified which affect patients with cancer, especially in the phase of cellular destruction after chemotherapy. The detection of these hyperuricemic syndromes, together with the improved understanding of urate handling by the kidney, have spurred new interest in the pathophysiology of hyperuricemic states, their clinical consequences and management. Moreover, the recent development of a recombinant form of urate oxidase transforming uric acid into allantoin (Rasburicase) has caused new interest in the pathophysiology of hyperuricemia and the potential applications of this new drug.
The multidisciplinary approach of this book offers new insights into the metabolic syndromes in question by uniting authors from the fields of biochemistry, pharmacology, rheumatology, onco-hematology, and nephrology. The result is a compendium of the present knowledge in the field, which will also be very useful as a reference tool for professionals and students who want to expand their knowledge on this topic.
Contributions to Nephrology,
Vol. 147
ISSN: 0302-5144
e-ISSN: 1662-2782
Hyperuricemic Syndromes: Pathophysiology and Therapy
Editor(s):
Ronco, C. (Vicenza);
Rodeghiero, F. (Vicenza)
X + 178 p.,
21 fig.,
5 in color,
15 tab.,
hard cover,
2005
Status: available
 |
|
|
|
|
| |
CHF |
EUR |
USD |
|
| |
|
(Germany only) |
(USA only) |
|
| List price |
228.- |
163.- |
207.25 |
|
|
| Prices subject to change |
Order this title
 Print Edition
Online Edition
Order Information
ISBN: 978-3-8055-7857-8
e-ISBN: 978-3-318-01169-2
|
|
|
| Search in this book
|
|
|
|
Title Index
Book Series
Series Home